SALIX PHARMACEUTICALS LTD Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
SALIX PHARMACEUTICALS LTD had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $20.20 million as of 2014-01-02, per its 10-Q/A filed 2015-03-02.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2015-03-02
- 2014-01-02: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $20.20M; Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets as first filed $21.50M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets as first filed |
|---|---|---|
| 2014-01-02 | $20.20M 10-Q/A · filed 2015-03-02 | $21.50M 10-Q · filed 2014-05-09 |